Toronto, Canada – BTNX Inc. has launched a series of Rapid Response® advanced FDA approved in-vitro diagnostic drugs of abuse tests, which are used for home, professional and corporation point of care drugs of abuse testing.The drug tests can easily detect any of Amphetamine, Barbiturate, Benzodiazepine, Buprenorphine, Cocaine, Ecstasy, EDDP (Methadone Metabolite), Heroin, Marijuana, Methadone, [...]